MicroRNA May Predict Response to Bevacizumab

Links shared publicly online about this topic.

  • 332
    total visits

MicroRNA May Predict Response to Bevacizumab

onclive.com

The results of a small clinical trial showed that low-level expression of a microRNA correlated with improved progression-free survival

View full resource at onclive.com

Tags: Cancer, Colorectal Cancer Medication, Ovarian Cancer, Clinical Trial, Women's Health, Avastin

  • Share

Most Recently Shared on April 28, 2011 at 3:01 pm By:

ONClive Editor

MicroRNA May Predict Response to Bevacizumab (Avastin) in Advanced Ovarian Cancer http://goo.gl/OcVAM

12 months ago...

Medical News: SGO: MicroRNA May Help Predict Ovarian Ca Response - in Meeting Coverage, SGO from MedPage Today

medpagetoday.com — “ORLANDO -- Changes in expression of a microRNA showed potential for predicting response to the angiogenesis inhibitor bevacizumab (Avastin) in recurrent serous ovarian cancer, according to results ofView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 8, 2011 at 4:25 pm By:

FightCancer FightCancer Health News

SGO: MicroRNA May Help Predict Ovarian Ca Response (CME/CE) http://bit.ly/hdTEao

1 year ago...

Medical News: SGO: MicroRNA May Help Predict Ovarian Ca Response - in Meeting Coverage, SGO from MedPage Today

medpagetoday.com — “ORLANDO -- Changes in expression of a microRNA showed potential for predicting response to the angiogenesis inhibitor bevacizumab (Avastin) in recurrent serous ovarian cancer, according to results ofView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 8, 2011 at 4:11 pm By:

MedicalNews Medical News Health News

SGO: MicroRNA May Help Predict Ovarian Ca Response (CME/CE) http://bit.ly/gmDtKs

1 year ago...

Short Strand of RNA May Help Predict Survival and Response to Treatment for Patients with Liver Cancer

physorg.com — “(PhysOrg.com) -- A small RNA molecule, known as a microRNA, may help physicians identify liver cancer patients who, in spite of their poor prognosis, could respond well to treatment with a biological agent called interferon. The finding, by scientists at the National Cancer Institute (NCI), part of ...View full resource at physorg.com

  • View Related
  • Share

Most Recently Shared on October 8, 2009 at 3:06 pm By:

FightCancer FightCancer Health News

Short Strand of RNA May Help Predict Survival and Response to Treatment for Patients with Liver Cancer http://bit.ly/15Esq6

3 years ago...

Advertisement